SGRL Q2 : NET PROFIT DOWN 67% AT ₹1.63 CR (YOY), UP 46% (QOQ). WEAK (ON 1ST LOOK)

Revenue down 23% at ₹23.29 Cr (YOY), up 62% (QOQ). EBITDA down 59% at ₹3.94 Cr (YOY), up 17% (QOQ); margins 16.9% v 31.7% (YOY), 23.3% (QOQ).

Shree Ganesh Remedies Ltd